Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse.

Authors: Díaz-Díaz, Carol J; Ronnekleiv-Kelly, Sean M; Nukaya, Manabu; Geiger, Peter G; Balbo, Silvia; Dator, Romel; Megna, Bryant W; Carney, Patrick R; Bradfield, Christopher A; Kennedy, Gregory D

Published In Ann Surg, (2016 Sep)

Abstract: To determine the role of the aryl hydrocarbon receptor (AHR) in colitis-associated colorectal tumorigenesis.Colorectal cancer (CRC) is the third most commonly diagnosed cancer in United States. Chronic intestinal inflammation increases the risk for the development of CRC. We investigated the involvement of AHR, a ligand-activated transcriptional regulator, in colitis-associated colorectal tumorigenesis.We used a mouse model of colitis-associated colorectal tumorigenesis that employs treatment with azoxymethane and dextran sodium sulfate. We examined the role of AHR using both an Ahr-deletion mouse model (Ahr) and treatment with the AHR pro-agonist indole-3-carbinol (I3C). Incidence, multiplicity, and location of tumors were visually counted. Tumors were defined as neoplasms. Intestinal inflammation was assessed by quantitative PCR for proinflammatory markers and colon length. Data were evaluated and compared using GraphPad Prism software (version 6, La Jolla, CA).Tumor incidence was increased 32% in Ahr null mice and tumor multiplicity was approximately increased 3-fold compared with wild-type mice (2.4 vs 7; P < 0.05). Furthermore, tumor multiplicity was reduced 92% by treatment of I3C in wild-type mice, whereas the suppressor effect of I3C was not observed in Ahr null mice (P < 0.05).We found that AHR plays a protective role in colitis-associated colorectal tumorigenesis. This conclusion is based on the observations that Ahr null mice showed increased number of colorectal tumors, and mice treated with I3C exhibited fewer tumors. This study supports the use of AHR agonists such as I3C as a chemopreventive therapy for IBD-associated CRC in human patients.

PubMed ID: 27433903 Exiting the NIEHS site

MeSH Terms: Animals; Azoxymethane/pharmacology; Colitis/complications*; Colorectal Neoplasms/prevention & control*; DNA Damage; Dextran Sulfate; Gene Expression; Indoles/pharmacology; Indoles/therapeutic use; Mice; Mice, Inbred C57BL; RNA/analysis; Receptors, Aryl Hydrocarbon/agonists; Receptors, Aryl Hydrocarbon/physiology*

Back
to Top